Guanidinoacetate Methyltransferase Deficiency
Guanidinoacetate methyltransferase (GAMT) deficiency is an autosomal recessively inherited disorder of the metabolism of creatine that leads to depleted levels of creatine and excessive concentrations of guanidinoacetate (GAA). Patients affected develop neurological symptoms during childhood, such a...
Main Authors: | Eduardo P. Marques, Angela T. S. Wyse PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SciELO
2016-10-01
|
Series: | Journal of Inborn Errors of Metabolism and Screening |
Online Access: | https://doi.org/10.1177/2326409816669371 |
Similar Items
-
Case series of creatine deficiency syndrome due to guanidinoacetate methyltransferase deficiency
by: Vinu Narayan, et al.
Published: (2020-01-01) -
Mild guanidinoacetate increase under partial guanidinoacetate methyltransferase deficiency strongly affects brain cell development
by: Layane Hanna-El-Daher, et al.
Published: (2015-07-01) -
Guanidinoacetate methyltransferase (GAMT) deficiency, a cerebral creatine deficiency syndrome: A rare treatable metabolic disorder
by: Sangeetha Yoganathan, et al.
Published: (2020-01-01) -
Gene therapy for guanidinoacetate methyltransferase deficiency restores cerebral and myocardial creatine while resolving behavioral abnormalities
by: Eliav, A., et al.
Published: (2022) -
Age-Dependent Decline in Cardiac Function in Guanidinoacetate-N-Methyltransferase Knockout Mice
by: Dunja Aksentijević, et al.
Published: (2020-01-01)